BMED saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 36 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 78%.
The 10-day RSI Indicator for BMED moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 24 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 66 cases where BMED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMED as a result. In 72 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
BMED broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 223 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 216 of 281 cases where BMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
The Moving Average Convergence Divergence (MACD) for XLV turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 42 of 48 cases over the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 73 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.
Following a +0.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 264 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 231 of 272 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The 10-day RSI Indicator for XLV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 26 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 67 cases where XLV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
XLV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| BMED | XLV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 69% | 3 days ago 70% |
| Stochastic ODDS (%) | 3 days ago 74% | 3 days ago 75% |
| Momentum ODDS (%) | 3 days ago 75% | 3 days ago 76% |
| MACD ODDS (%) | 3 days ago 78% | 6 days ago 88% |
| TrendWeek ODDS (%) | 3 days ago 73% | 3 days ago 82% |
| TrendMonth ODDS (%) | 3 days ago 81% | 3 days ago 84% |
| Advances ODDS (%) | 7 days ago 82% | 5 days ago 81% |
| Declines ODDS (%) | 3 days ago 77% | 10 days ago 81% |
| BollingerBands ODDS (%) | 3 days ago 64% | 3 days ago 80% |
| Aroon ODDS (%) | 3 days ago 77% | 3 days ago 85% |
A.I.dvisor tells us that BMED and CRL have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMED and CRL's prices will move in lockstep.
| Ticker / NAME | Correlation To BMED | 1D Price Change % | ||
|---|---|---|---|---|
| BMED | 100% | -0.34% | ||
| CRL - BMED | 16% Poorly correlated | -0.83% | ||
| BDX - BMED | 15% Poorly correlated | +1.08% | ||
| MCRB - BMED | 13% Poorly correlated | -0.71% | ||
| GKOS - BMED | 13% Poorly correlated | -0.13% | ||
| VRTX - BMED | 13% Poorly correlated | -0.74% | ||
More | ||||
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| YINN | 23.15 | 0.02 | +0.09% |
| Direxion Daily FTSE China Bull 3X ETF (YINN) | |||
| GRX | 10.41 | -0.01 | -0.10% |
| Gabelli Healthcare & Wellness Trust (The) | |||
| APRT | 47.12 | -0.05 | -0.11% |
| AllianzIM U.S. Equity Buffer10 Apr ETF (APRT) | |||
| VWOB | 63.27 | -0.13 | -0.21% |
| Vanguard Emerging Markets Government Bond ETF (VWOB) | |||
| SPCK | 21.59 | -0.05 | -0.23% |
| SPAC and New Issue ETF (SPCK) | |||